Combination of immune check inhibitor and immunomodulatory arabinomannan extracted from Mycobacterium tuberculosis: A case report

The present study selected two patients with lung cancer and epidermal growth factor receptor (EGFR) mutations who were treated with a programmed cell death protein 1 (PD-1) antibody and an immunomodulatory arabinomannan extracted from Mycobacterium tuberculosis. In the first case, a 67-year-old fem...

Descripción completa

Detalles Bibliográficos
Autores principales: Kobayashi, Kunihiko, Kaira, Kyoichi, Iemura, Hidetoshi, Shinomiya, Shun, Hashimoto, Kosuke, Miura, Yu, Shiono, Ayako, Nishihara, Fuyumi, Kagamu, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8461616/
https://www.ncbi.nlm.nih.gov/pubmed/34631053
http://dx.doi.org/10.3892/mco.2021.2390

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8461616/
https://www.ncbi.nlm.nih.gov/pubmed/34631053
http://dx.doi.org/10.3892/mco.2021.2390

Ejemplares similares